Can Investigators Appeal Adverse IRB Decisions?

IRB: Ethics & Human Research 2 (3):8 (1980)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.2307/3564493

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,174

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Coercion in the Recruitment and Retention of Human Research Subjects, Pharmaceutical Industry Payments to Physician-Investigators and the Moral Courage of the IRB.Evan G. DeRenzo - 2000 - IRB: Ethics & Human Research 22 (2):1.
IRB Review of Adverse Events in Investigational Drug Studies. [REVIEW]Ernest D. Prentice & Bruce Gordon - 1997 - IRB: Ethics & Human Research 19 (6):1.
The Measure of Investigators' Reputations.Marlene S. Wagner - 1985 - IRB: Ethics & Human Research 7 (4):8.
Opening Closed Doors: Promoting IRB Transparency.Holly Fernandez Lynch - 2018 - Journal of Law, Medicine and Ethics 46 (1):145-158.
Moral Duties of Investigators toward Sick Children.Terrence F. Ackerman - 1981 - IRB: Ethics & Human Research 3 (6):1.
Informed Consent: Practices and Views of Investigators in a Multinational Clinical Trial.Lindsay Sabik, Christine A. Pace, Heidi P. Forster-Gertner, David Wendler, Judith D. Bebchuk, Jorge A. Tavel, Laura A. McNay, Jack Killen, Ezekiel J. Emanuel & Christine Grady - 2004 - IRB: Ethics & Human Research 27 (5):13-18.
All the Adverse Effects of Drawing Blood.Susanne S. Robb - 1985 - IRB: Ethics & Human Research 7 (3):7.
Informed Consent for Alzheimer's Disease Clinical Trials: A Survey of Clinical Investigators.Jason H. T. Karlawish, David Knopman, Christopher M. Clark, John C. Morris, Daniel Marson, Peter J. Whitehouse & Claudia H. Kawas - 2002 - IRB: Ethics & Human Research 24 (5):1.
Institutional Review Board (IRB): US Perspectives.Maria I. Lapid, Yves Ouellette, Matthew T. Drake & Bart L. Clarke - 2023 - In Erick Valdés & Juan Alberto Lecaros (eds.), Handbook of Bioethical Decisions. Volume II: Scientific Integrity and Institutional Ethics. Springer Verlag. pp. 2147483647-2147483647.
Why I oppose drug company payment of physician/investigators on a per patient/subject basis.Ron Roizen - 1988 - IRB: Ethics & Human Research 10 (1):9.

Analytics

Added to PP
2021-04-28

Downloads
5 (#1,752,423)

6 months
5 (#1,047,105)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references